Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction

Diabetic Medicine

Volumn 23, Issue 12, 2006, Pages 1370-1376

  Schiele, F ^a   Descotes Genon, V ^a   Seronde, M F ^a   Blonde, M C ^a   Legalery, P ^a   Meneveau, N ^a   Ecarnot, F ^a   Mercier, M ^a   Penfornis, A ^a   Thebault, L ^a   Boumal, D ^a   Bassand, J P ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Diabetes; Myocardial infarction; Risk score; Stress hyperglycaemia

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MORTALITY; RISK FACTOR; SCORING SYSTEM; ST SEGMENT ELEVATION;

AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; MALE; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS;

EID: 33751245552     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.02000.x     Document Type: Article

References (32)

1. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773-778.
2. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ (Clin Res Ed) 1986; 293: 917-922.
3. Timmer JR, Van Der Horst IC, Ottervanger JP, Henriques JP, Hoorntje JC, De Boer MJ et al. Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J 2004; 148: 399-404.
4. Tansey MJ, Opie LH. Plasma glucose on admission to hospital as a metabolic index of the severity of acute myocardial infarction. Can J Cardiol 1986; 2: 326-331.
5. Zeller M, Cottin Y, Brindisi MC, Dentan G, Laurent Y, Janin-Manificat L et al. Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction. Eur Heart J 2004; 25: 308-312.
6. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005; 111: 754-760.
7. Nordin C, Amiruddin R, Rucker L, Choi J, Kohli A, Marantz PR. Diabetes and stress hyperglycemia associated with myocardial infarctions at an urban municipal hospital: prevalence and effect on mortality. Cardiol Rev 2005; 13: 223-230.
8. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G et al. The TIMI risk score for unstable angina/non-ST elevation MI. A method for prognostication and therapeutic decision making. JAMA 2000; 284: 835-842.
9. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000; 102: 2031-2037.
10. Morrow DA, Antman EM, Giugliano RP, Cairns R, Charlesworth A, Murphy SA et al. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy. Lancet 2001; 358: 1571-1575.
11. Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000; 101: 2557-2567.
12. Sabatine MS, Januzzi JL, Snapinn S, Theroux P, Jang IK. A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris. Am J Cardiol 2001; 88: 488-492.
13. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004; 291: 2727-2733.
14. Jacobs DR Jr, Kroenke C, Crow R, Deshpande M, Gu DF, Gatewood L et al. PREDICT: A simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota heart survey. Circulation 1999; 100: 599-607.
15. Krumholz HM, Chen J, Chen YT, Wang Y, Radford MJ. Predicting one-year mortality among elderly survivors of hospitalization for an acute myocardial infarction: results from the Cooperative Cardiovascular Project. J Am Coll Cardiol 2001; 38: 453-459.
16. Gulati M, Patel S, Jaffe AS, Joseph AJ, Calvin JE Jr. Impact of contemporary guideline compliance on risk stratification models for acute coronary syndromes in The Registry of Acute Coronary Syndromes. Am J Cardiol 2004; 94: 873-878.
17. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 2004; 109: 745-749.
18. Schiele F, Meneveau N, Seronde MF, Caulfield F, Fouche R, Lassabe G et al. Compliance with guidelines and 1-year mortality in patients with acute myocardial infarction: a prospective study. Eur Heart J 2005; 26: 873-880.
19. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA 2004; 292: 2096-2104.
20. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
21. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003; 163: 2345-2353.
22. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.
23. Song HH. Analysis of correlated ROC areas in diagnostic testing. Biometrics 1997; 53: 370-382.
24. Peterson ED, Pollack CV Jr, Roe MT, Parsons LS, Littrell KA, Canto JG et al. Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4. J Am Coll Cardiol 2003; 42: 45-53.
25. Schnell O, Schafer O, Kleybrink S, Doering W, Standl E, Otter W. Intensification of therapeutic approaches reduces mortality in diabetic patients with acute myocardial infarction: The Munich registry. Diabetes Care 2004; 27: 455-460.
26. Malmberg K, Ryden L, Hamsten A, Herlitz J, Waldenstrom A, Wedel H. Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study. Cardiovasc Res 1997; 34: 248-253.
27. Allen LA, O'Donnell CJ, Giugliano RP, Camargo CA Jr, Lloyd-Jones DM. Care concordant with guidelines predicts decreased long-term mortality in patients with unstable angina pectoris and non-ST-elevation myocardial infarction. Am J Cardiol 2004; 93: 1218-1222.
28. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140-2144.
29. Bartnik M, Malmberg K, Hamsten A, Efendic S, Norhammar A, Silveira A et al. Abnormal glucose tolerance - a common risk factor in patients with acute myocardial infarction in comparison with population-based controls. J Intern Med 2004; 256: 288-297.
30. Bartnik M, Malmberg K, Norhammar A, Tenerz Ohrvik J, Ryden L. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004; 25: 1990-1997.
31. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367.
32. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999; 99: 2626-2632.